XNCR May 2024 20.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
At close: 03:32PM EDT
| Previous Close | 2.6600 |
| Open | 2.6600 |
| Bid | 0.0000 |
| Ask | 5.0000 |
| Strike | 20.00 |
| Expire Date | 2024-05-17 |
| Day's Range | 2.6600 - 2.6600 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 13 |
- GuruFocus.com
Xencor Inc (XNCR) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
Comprehensive Analysis of Financial Performance and Strategic Initiatives
Business WireXencor Reports First Quarter 2024 Financial Results
PASADENA, Calif., May 09, 2024--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the first quarter ended March 31, 2024 and provided a review of recent clinical and business highlights.
ZacksXencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Xencor (XNCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.